To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects
Clinical trial NCT02063204 · COMPLETED
Trial details
- NCT number
- NCT02063204
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-07-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.